Oncology & Cancer

Researchers present advance in re-treatment with CAR T therapy

Researchers from the University of Pennsylvania's Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating successful re-treatment with CAR T cell therapy for patients whose ...

Oncology & Cancer

Discovery suggests new way to target mantle cell lymphoma

A form of blood cancer known as mantle cell lymphoma is critically dependent on a protein that coordinates gene expression, such that blocking its activity with an experimental drug dramatically slows the growth of this lymphoma ...

Oncology & Cancer

Q&A: What is lymphoma?

My sister recently noticed significantly enlarged lymph nodes in her neck. Her primary care physician said he thought she had lymphoma. What is lymphoma and what is her prognosis? Is it hereditary?

Oncology & Cancer

What is CAR-T cell therapy?

Roughly 620,000 new cases of lymphoma were diagnosed worldwide, according to the World Cancer Research Fund International's 2020 report. Survival rates have improved as advances develop in treatment, such as chimeric antigen ...

Oncology & Cancer

Enzyme inhibitor slows tumor growth

Together with researchers from University Hospital Mainz, the University of Regensburg and the IRCM in Montreal (Canada), a research team from Friedrich Schiller University Jena has discovered a novel therapeutic approach ...

Medical research

Nature-inspired peptide shows anti-tumor activity

An Austrian study demonstrates an anti-tumor effect of certain nature-derived cyclic peptides. The study, which has now been published internationally, not only demonstrates the inhibition of cell division by these peptides, ...

Oncology & Cancer

Mental illness elevated among Hodgkin lymphoma patients

Patients with Hodgkin lymphoma (HL) are more likely to suffer from mental-health and substance-abuse disorders than the general population. Calling for more attention to mental health, a study published August 2 in Cancer ...

Oncology & Cancer

Mantle cell lymphoma treatment varies according to setting

There is considerable variation in the management of mantle cell lymphoma across different clinical settings, and some strategies do not always conform with what might be expected, according to an analysis by investigators ...

page 5 from 40